Shishir Gadam
Technik-/Wissenschafts-/F&E-Leiter bei CARGO THERAPEUTICS, INC.
Vermögen: 538 894 $ am 30.04.2024
Profil
Shishir Gadam is currently a Member at Roche Group and the Chief Technical Officer at Cargo Therapeutics, Inc. He previously worked as the VP-Global Cell Therapy Manufacturing Science at Juno Therapeutics, Inc. Gadam holds a doctorate degree from Rensselaer Polytechnic Institute, a graduate degree from West Virginia University, and an undergraduate degree from the University of Mumbai.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
0,07% | 01.03.2024 | 29 480 ( 0,07% ) | 538 894 $ | 30.04.2024 |
Aktive Positionen von Shishir Gadam
| Unternehmen | Position | Beginn |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Shishir Gadam
| Unternehmen | Position | Ende |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | - |
Ausbildung von Shishir Gadam
| Rensselaer Polytechnic Institute | Doctorate Degree |
| West Virginia University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARGO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
